Clinical Trial Update: A Phase Ib Study of GC101 in NSCLC [Phase 1]

View source ↗

Summary

This document reports a Phase Ib clinical trial evaluating GC101 in non-small cell lung cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• GC101

Snippet

Sponsor: Shanghai Juncell Therapeutics | Conditions: Non Small Cell Lung Cancer Metastatic, Non Small Cell Lung Cancer | Phase 1 | Status: RECRUITING